177 related articles for article (PubMed ID: 35357426)
1. Defining novel causal SNPs and linked phenotypes at melanoma-associated loci.
Castaneda-Garcia C; Iyer V; Nsengimana J; Trower A; Droop A; Brown KM; Choi J; Zhang T; Harland M; Newton-Bishop JA; Bishop DT; Adams DJ; Iles MM; Robles-Espinoza CD
Hum Mol Genet; 2022 Aug; 31(17):2845-2856. PubMed ID: 35357426
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2.
Ibarrola-Villava M; Fernandez LP; Pita G; Bravo J; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
Exp Dermatol; 2010 Sep; 19(9):836-44. PubMed ID: 20629734
[TBL] [Abstract][Full Text] [Related]
3. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
[TBL] [Abstract][Full Text] [Related]
4. MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis.
Ibarrola-Villava M; Hu HH; Guedj M; Fernandez LP; Descamps V; Basset-Seguin N; Bagot M; Benssussan A; Saiag P; Fargnoli MC; Peris K; Aviles JA; Lluch A; Ribas G; Soufir N
Eur J Cancer; 2012 Sep; 48(14):2183-91. PubMed ID: 22464347
[TBL] [Abstract][Full Text] [Related]
5. A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.
Han J; Qureshi AA; Nan H; Zhang J; Song Y; Guo Q; Hunter DJ
Cancer Res; 2011 Mar; 71(5):1533-9. PubMed ID: 21270109
[TBL] [Abstract][Full Text] [Related]
6. A large French case-control study emphasizes the role of rare Mc1R variants in melanoma risk.
Hu HH; Benfodda M; Dumaz N; Gazal S; Descamps V; Bourillon A; Basset-Seguin N; Riffault A; Ezzedine K; Bagot M; Bensussan A; Saiag P; Grandchamp B; Soufir N
Biomed Res Int; 2014; 2014():925716. PubMed ID: 24982914
[TBL] [Abstract][Full Text] [Related]
7. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas.
Helsing P; Nymoen DA; Rootwelt H; Vårdal M; Akslen LA; Molven A; Andresen PA
Genes Chromosomes Cancer; 2012 Jul; 51(7):654-61. PubMed ID: 22447455
[TBL] [Abstract][Full Text] [Related]
8. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
[TBL] [Abstract][Full Text] [Related]
9. Melanoma risk associated with MC1R gene variants in Latvia and the functional analysis of rare variants.
Ozola A; Azarjana K; Doniņa S; Proboka G; Mandrika I; Petrovska R; Cēma I; Heisele O; Eņģele L; Streinerte B; Pjanova D
Cancer Genet; 2013 Mar; 206(3):81-91. PubMed ID: 23522749
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.
Chatzinasiou F; Lill CM; Kypreou K; Stefanaki I; Nicolaou V; Spyrou G; Evangelou E; Roehr JT; Kodela E; Katsambas A; Tsao H; Ioannidis JP; Bertram L; Stratigos AJ
J Natl Cancer Inst; 2011 Aug; 103(16):1227-35. PubMed ID: 21693730
[TBL] [Abstract][Full Text] [Related]
11. Variants at the 9p21 locus and melanoma risk.
Maccioni L; Rachakonda PS; Bermejo JL; Planelles D; Requena C; Hemminki K; Nagore E; Kumar R
BMC Cancer; 2013 Jul; 13():325. PubMed ID: 23816148
[TBL] [Abstract][Full Text] [Related]
12. MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study.
Cust AE; Goumas C; Holland EA; Agha-Hamilton C; Aitken JF; Armstrong BK; Giles GG; Kefford RF; Schmid H; Hopper JL; Mann GJ; Jenkins MA
Int J Cancer; 2012 Aug; 131(3):E269-81. PubMed ID: 22095472
[TBL] [Abstract][Full Text] [Related]
13. CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.
Karagianni F; Njauw CN; Kypreou KP; Stergiopoulou A; Plaka M; Polydorou D; Chasapi V; Pappas L; Stratigos IA; Champsas G; Panagiotou P; Gogas H; Evangelou E; Tsao H; Stratigos AJ; Stefanaki I
Acta Derm Venereol; 2018 Oct; 98(9):862-866. PubMed ID: 29774366
[TBL] [Abstract][Full Text] [Related]
14. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
15. Inherited genetic variants associated with occurrence of multiple primary melanoma.
Gibbs DC; Orlow I; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):992-7. PubMed ID: 25837821
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identifies three loci associated with melanoma risk.
Bishop DT; Demenais F; Iles MM; Harland M; Taylor JC; Corda E; Randerson-Moor J; Aitken JF; Avril MF; Azizi E; Bakker B; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Cannon-Albright LA; Chin-A-Woeng T; Debniak T; Galore-Haskel G; Ghiorzo P; Gut I; Hansson J; Hocevar M; Höiom V; Hopper JL; Ingvar C; Kanetsky PA; Kefford RF; Landi MT; Lang J; Lubiński J; Mackie R; Malvehy J; Mann GJ; Martin NG; Montgomery GW; van Nieuwpoort FA; Novakovic S; Olsson H; Puig S; Weiss M; van Workum W; Zelenika D; Brown KM; Goldstein AM; Gillanders EM; Boland A; Galan P; Elder DE; Gruis NA; Hayward NK; Lathrop GM; Barrett JH; Bishop JA
Nat Genet; 2009 Aug; 41(8):920-5. PubMed ID: 19578364
[TBL] [Abstract][Full Text] [Related]
17. Variants at chromosome 20 (ASIP locus) and melanoma risk.
Maccioni L; Rachakonda PS; Scherer D; Bermejo JL; Planelles D; Requena C; Hemminki K; Nagore E; Kumar R
Int J Cancer; 2013 Jan; 132(1):42-54. PubMed ID: 22628150
[TBL] [Abstract][Full Text] [Related]
18. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
19. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma.
Amos CI; Wang LE; Lee JE; Gershenwald JE; Chen WV; Fang S; Kosoy R; Zhang M; Qureshi AA; Vattathil S; Schacherer CW; Gardner JM; Wang Y; Bishop DT; Barrett JH; ; MacGregor S; Hayward NK; Martin NG; Duffy DL; ; Mann GJ; Cust A; Hopper J; ; Brown KM; Grimm EA; Xu Y; Han Y; Jing K; McHugh C; Laurie CC; Doheny KF; Pugh EW; Seldin MF; Han J; Wei Q
Hum Mol Genet; 2011 Dec; 20(24):5012-23. PubMed ID: 21926416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
